In the BioHarmony Drug Report Database
Ceftaroline fosamil
Teflaro, Zinforo (ceftaroline fosamil) is a small molecule pharmaceutical. Ceftaroline fosamil was first approved as Teflaro on 2010-10-29. It is used to treat escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, and staphylococcal infections amongst others in the USA. It has been approved in Europe to treat community-acquired infections, infectious skin diseases, and pneumonia. Teflaro’s patents are valid until 2031-02-10 (FDA).
Trade Name
|
Zinforo |
|---|---|
Common Name
|
ceftaroline fosamil |
ChEMBL ID
|
CHEMBL501122 |
Indication
|
community-acquired infections, escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, staphylococcal infections, streptococcal infections |
Drug Class
|
Cephalosporins; phosphoro-derivatives |
Image (chem structure or protein)